X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (233) 233
ophthalmology (227) 227
bevacizumab (177) 177
humans (170) 170
subconjunctival bevacizumab (128) 128
male (121) 121
female (107) 107
endothelial growth-factor (102) 102
corneal neovascularization (97) 97
angiogenesis (89) 89
eye diseases (85) 85
angiogenesis inhibitors - administration & dosage (75) 75
middle aged (73) 73
animals (72) 72
vascular endothelial growth factor a - antagonists & inhibitors (71) 71
neovascularization (67) 67
sense organs (67) 67
adult (64) 64
cornea (63) 63
genetic structures (61) 61
glaucoma (61) 61
avastin (60) 60
vascular endothelial growth factor (59) 59
aged (57) 57
corneal neovascularization - drug therapy (55) 55
surgery (53) 53
intravitreal bevacizumab (50) 50
subconjunctival (49) 49
inhibition (48) 48
macular edema (48) 48
mitomycin c (48) 48
topical bevacizumab (48) 48
treatment outcome (48) 48
angiogenesis inhibitors - therapeutic use (46) 46
inflammation (46) 46
intraocular pressure (46) 46
subconjunctival bevacizumab injection (46) 46
subconjunctival injection (45) 45
macular degeneration (44) 44
visual acuity (44) 44
branch retinal vein occlusion (42) 42
optical coherence tomography (42) 42
conjunctiva (40) 40
disease models, animal (40) 40
injection (40) 40
triamcinolone (38) 38
antibodies, monoclonal, humanized - administration & dosage (37) 37
excision (36) 36
intravitreal (36) 36
follow-up studies (35) 35
triamcinolone acetonide (35) 35
blindness (33) 33
keratoconus (33) 33
rabbits (33) 33
antibodies, monoclonal, humanized (32) 32
mitomycin-c (32) 32
pterygium surgery (32) 32
quality of life (32) 32
therapy (32) 32
trabeculectomy (32) 32
antimicrobial effect (31) 31
conventional silicone oil (31) 31
disability evaluation (31) 31
endophthalmitis agents (31) 31
expression (31) 31
heavy silicone oil (31) 31
mean deviation (31) 31
modified deep anterior lamellar keratoplasty (31) 31
non-proliferative diabetic retinopathy (31) 31
pterygium recurrence (31) 31
short fluctuations (31) 31
short wave automated perimetry (31) 31
standard automated perimetry (31) 31
steep corneal curvature (31) 31
imaging in glaucoma (30) 30
pediatric (30) 30
recurrent pterygium (30) 30
retinal nerve fiber layer (30) 30
antibodies, monoclonal - administration & dosage (29) 29
autogenous tissue grafting (29) 29
bypass surgery (29) 29
care and treatment (29) 29
cataract (29) 29
eye (29) 29
growth factors (29) 29
keratoplasty (29) 29
lacrimal drainage system (29) 29
lacrimal fossa (29) 29
myopia (29) 29
photorefractive keratectomy (29) 29
ranibizumab (29) 29
corneal neovascularization - pathology (28) 28
excimer laser (28) 28
in vitro (28) 28
research (28) 28
human trabecular meshwork cells (27) 27
injections (27) 27
vegf (27) 27
dacryocystorhinostomy (26) 26
hyperopic implantable collamer lens (26) 26
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of Ophthalmology, ISSN 2090-004X, 2018, Volume 2018, pp. 8965709 - 13
The present study aimed at observing the effect of a single subconjunctival injection of bevacizumab (BVZ) combined with 5-fluorouracil (5-Fu) or mitomycin C... 
MEDICINE, RESEARCH & EXPERIMENTAL | IN-VITRO | SCAR FORMATION | ANGIOGENESIS | FILTERING SURGERY | VEGF | OPHTHALMOLOGY | INTRAVITREAL BEVACIZUMAB | SUBCONJUNCTIVAL BEVACIZUMAB | NEOVASCULAR GLAUCOMA | TRABECULECTOMY | ENDOTHELIAL GROWTH-FACTOR | Eye | Animal experimentation | Glaucoma | Mitomycin | RNA | Surgery | Angiogenesis inhibitors | Vascular endothelial growth factor | Fluorouracil
Journal Article
PLoS ONE, ISSN 1932-6203, 04/2014, Volume 9, Issue 4, pp. e94205 - e94205
Purpose: To evaluate the effects and underlying mechanisms of early and late subconjunctival injection of bevacizumab on the inhibition of corneal... 
BLOOD-VESSEL MATURATION | ANTI-VEGF | ANGIOGENESIS | PROLIFERATIVE DIABETIC-RETINOPATHY | TYROSINE KINASE | MULTIDISCIPLINARY SCIENCES | MACULAR DEGENERATION | OCULAR NEOVASCULARIZATION | PDGF-B | SUBCONJUNCTIVAL BEVACIZUMAB | ENDOTHELIAL GROWTH-FACTOR | Immunohistochemistry | Rabbits | Corneal Neovascularization - drug therapy | Actins - metabolism | Angiogenesis Inhibitors - pharmacology | Vascular Endothelial Growth Factor Receptor-2 - metabolism | Vascular Endothelial Growth Factor Receptor-1 - metabolism | Vascular Endothelial Growth Factor A - metabolism | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Bevacizumab | Cornea - metabolism | Angiogenesis Inhibitors - administration & dosage | Animals | Antibodies, Monoclonal, Humanized - administration & dosage | Cornea - drug effects | Platelet Endothelial Cell Adhesion Molecule-1 - metabolism | Antibodies, Monoclonal, Humanized - pharmacology | Antigens, Neoplasm - metabolism | Cornea - pathology | Corneal Neovascularization - pathology | Corneal Neovascularization - etiology | Eye diseases | Diagnosis | Drug therapy | Vascular endothelial growth factor | Health aspects | Diabetic retinopathy | Cornea | Smooth muscle | Biochemistry | Macrophages | Vascularization | Angiogenesis | Receptors | Silk | Ischemia | Inhibition | Diffusion | Polyclonal antibodies | Tissue engineering | Stroma | Muscles | Blood vessels | Injection | Epithelium | Studies | Stem cells | Pericytes | Infiltration | Diabetes | Molecular biology | Cancer | Apoptosis | Tumors | Eye lens | Index Medicus
Journal Article
PLoS ONE, ISSN 1932-6203, 01/2017, Volume 12, Issue 1, pp. e0169675 - e0169675
Journal Article
Investigative Ophthalmology and Visual Science, ISSN 0146-0404, 09/2016, Volume 57, Issue 11, pp. 4916 - 4926
PURPOSE. Retinoblastoma (Rb) is a rare childhood cancer of the retina with a survival rate of 95% in children living in high-income countries, after... 
Carboplatin | Patient-derived xenografts | Retinoblastoma | PDX | Bevacizumab | CONSERVATIVE THERAPY | MANAGEMENT | PHOTODYNAMIC THERAPY | PHASE-I/II | VEGF | SUBCONJUNCTIVAL CARBOPLATIN | patient-derived xenografts | INTRAARTERIAL CHEMOTHERAPY | INTRAOCULAR RETINOBLASTOMA | retinoblastoma | carboplatin | bevacizumab | OPHTHALMOLOGY | EXPRESSION | ENDOTHELIAL GROWTH-FACTOR
Journal Article
Journal of Glaucoma, ISSN 1057-0829, 01/2015, Volume 24, Issue 1, pp. 25 - 31
Journal Article